Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03343067
Recruitment Status : Terminated (Strategic considerations)
First Posted : November 17, 2017
Last Update Posted : October 8, 2018
Sponsor:
Information provided by (Responsible Party):
AbbVie

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : September 4, 2018
  Actual Study Completion Date : September 4, 2018